What is your preferred subsequent treatment in patients with metastatic bladder cancer with progression on pembrolizumab/enfortumab?
In non-FGFR mutated patients, would you use cisplatin/gemcitabine or sacituzimab govitecan at this point?
Community PollStarted
What is your preferred regimen for patients with metastatic bladder cancer, non-FGFR mutated, who are platinum eligible and progressed on pembrolizumab/enfortumab?
58 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Northwestern University
Answered on
Given the fundamental change associated with bringing 2 agents, previously approved for salvage therapy after chemotherapy for metastatic urothelial cancer, forward to first line treatment has left practitioners wondering what the correct sequence of therapy should now be in salvage.
This will likel...
Join for free or sign in to see the full answer